We performed a meta-analysis to compare the efficacy and safety between low- and standard-dose intravenous (IV) tissue-type plasminogen activator (tPA) for acute ischemic stroke (AIS) patients within 4.5 hours of symptom onset.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...